Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide Nasal Aerosol in Children with Seasonal Allergic Rhinitis
NCT01458275Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Nov 2011
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in seasonal allergic rhinitis (SAR), sponsored by Sumitomo Pharma America. Started Nov 2011; status: completed.
02
Drugs
ciclesonide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01458275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458275.